Oclacitinib Maleate Tablets
Supplier Details
Hebei Weierli Animal Healthcare Group Co.,Ltd
Free Member (2026)
[ Shijiazhuang City, HB,China ]
Business Type: Manufacturer
Supplier has 5 products
Product Description
Active ingredient
Oclacitinib Maleate
Appearance
This product is a light brown or brown, cross-scored tablet.
Dosage and Administration
Calculated as oclacitinib. Oral administration: For dogs, 0.4 ? 0.6 mg per 1 kg of body weight, twice a day for 14 consecutive days, and then once a day for maintenance therapy.
Oclacitinib is a synthetic intracellular non-receptor tyrosine kinase Janus kinase, JAK for short inhibitor. It inhibits the function of a variety of pruritogenic cytokines and pro-inflammatory cytokines, as well as cytokines involved in allergy that are dependent on JAK1 or JAK3 enzyme activity. It has little effect on cytokines involved in hematopoiesis that are dependent on JAK2.
Basic Information
Country:
China
Business Type:
Manufacturer
Year Established:
2015
Total Employees:
101 - 500
About Us
The smart chemical factory uses advanced fully automated assembly line equipment, with production capacity up to:
Chinese medicine extraction workshop:
Annual processing of Chinese medicinal materials can reach more than 5,000 tons
Annual production of Chinese medicine extracts is more than 350 tons
Oral liquid workshop: annual output exceeds 12 million bottles
Granule/tablet workshop: annual production of granules is more than 300 tons, tablets are more than 200 million tablets
Member History
Year Joined:
2026
Membership Type:
Free Member
Send Supplier a Message
You must be signed in to contact this supplier.
